Financial

WELL Health to Exercise Call Right and Acquire Majority Controlling Interest in HEALWELL AI concurrent with HEALWELL’s Proposed Acquisition of Orion Health

WELL intends to amend and exercise its call right to acquire a majority controlling interest in HEALWELL AI concurrent with…

10 months ago

Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient…

10 months ago

Single-cell Analysis Market Surges to USD 5.4 Billion by 2033, Propelled by 9.5% CAGR – Verified Market Reports®

The Single-Cell Analysis Market is experiencing robust expansion, driven by surging demand for precision medicine, advancements in genomics, and rising investments…

11 months ago

Wellgistics Health Annual Letter to Shareholders From the Office of the CEO March 2025

Dear Shareholders, TAMPA, FL, March 27, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ: WGRX) (“Wellgistics Health”), This time last…

11 months ago

Chan Zuckerberg Initiative Announces New Biohub to Develop Breakthrough Imaging Technologies to Observe Cells in Action

The CZ Biohub San Francisco and CZ Imaging Institute will join together to develop novel imaging technologies that provide entirely…

11 months ago

ZAC Cognitive Explainable Artificial Intelligence (CXAI) recognized as a Top AI Algorithm/ Tech for Biotech/ Medical applications

POTOMAC, Md., March 26, 2025 /PRNewswire/ -- Z Advanced Computing, Inc. (ZAC), the pioneer Cognitive Explainable-AI (Artificial Intelligence) (Cognitive XAI…

11 months ago

New Jersey Innovation Institute and Cognome Announce Strategic Partnership to Advance AI-Powered Healthcare Solutions

NEWARK, N.J., March 26, 2025 /PRNewswire/ -- The New Jersey Innovation Institute (NJII), and Cognome are pleased to announce a strategic…

11 months ago

Patent Index 2024: US Innovation Remains Strong Despite Global Economic Uncertainties

U.S. ranks first in European patent applications, followed by Germany, Japan, China, and Republic of Korea European Patent Office (EPO) received…

11 months ago

Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces its Novel Inhibitors Show Promising In Silico Activity Against Measles and Related Viruses

These candidates, previously shown to be active in vitro against respiratory syncytial virus (RSV) and human parainfluenza virus 3 (hPIV3),…

11 months ago

Avant Technologies and Ainnova Begin Designing Clinical Trial Protocol for Company’s Vision AI Platform

LAS VEGAS, March 25, 2025 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), and its partner, Ainnova…

11 months ago